UPMA: unspecified pretraining and modular adaptation for context-aware target delineation in adaptive esophageal radiotherapy

Authors:

Abstract
Esophageal cancer, a serious malignancy, is primarily treated with radiotherapy (RT). Accurate delineation of gross tumor volume (GTV) and clinical target volume (CTV) is essential, yet manual contouring is time-consuming and automatic methods remain challenging. Adaptive radiotherapy enables personalized target adjustments, but tumor changes following initial RT complicate delineation, and automatic second-phase replanning is underexplored. We propose the Unspecified Pretraining and Modular Adaptation (UPMA) framework for context-aware second-phase esophageal target delineation. UPMA pretrains its network on diverse datasets to comprehend tumor and anatomical features, then modularly adapts it for second-phase tasks with minimal parameters. The method improves Dice scores by over 23% for GTV and over 5% for CTV, while reducing learnable parameters by over 73% during adaptation. In clinical evaluations, 73.7% and 52.6% of the predicted GTVs and CTVs required only minor edits. UPMA generalizes across diverse patient characteristics and imaging factors, supporting automated adaptive radiotherapy for precise, personalized treatment.
Funding Information
  • Guangdong Esophageal Cancer Institute Science and Technology Program (Q202311; Q202221; Q202214; Q202223; M-202016)
  • National Key Research and Development Program of China Stem Cell and Translational Research (2022YFC2405200)
  • National Natural Science Foundation of China (82027807, U22A2051)
  • Institute for Intelligent Healthcare, Tsinghua University (2022ZLB001)
  • Tsinghua-Foshan Innovation Special Fund (2021THFS0104)